title: Racial disparity in treatment of osteoporosis after diagnosis.
abstract: BACKGROUND
  Racial disparities have been identified in a number of areas in clinical medicine. Patients diagnosed with osteoporosis should be treated similarly regardless of race. However, limited data are available on the relative frequency of treatment by race after diagnosis of osteoporosis.
  
  
  METHODS
  We analyzed all 739 dual-energy X-ray absorptiometry (DXA) results obtained of women 50 years old and older between 1998 and 2002 at our medical center. Our study sample was 82% Caucasian and 15% African American. Of 353 women who had low bone mineral density on first DXA, we abstracted the electronic and paper medical records to compare treatment rates by race.
  
  
  RESULTS
  Of the women diagnosed with osteoporosis or osteopenia, 80.0% and 68.3%, respectively, were started on antiresorptive medications. Of the African American women, 61.9% diagnosed with osteoporosis were started on antiresorptive treatment compared with 83.3% of Caucasian women (p<0.05). African American women with low bone mass were less likely than Caucasian women to be smokers (p<0.05) and use alcohol (p<0.01) but were more likely to be on corticosteroids (p<0.05). No other significant differences were found among treated and nontreated groups that might explain the disparity in treatment.
  
  
  CONCLUSIONS
  A smaller proportion of African American than Caucasian women with osteoporosis received antiresorptive medications after a DXA diagnosis. This significant disparity requires further study in a larger population.
authors.affiliation: Brody School of Medicine, East Carolina University, Brody 4N-72A, 600 Moye Blvd, Greenville, NC, 27834, USA. hamricki@ecu.edu
authors.forename: I
authors.initials: I
authors.lastname: Hamrick
authors.forename: L M
authors.initials: LM
authors.lastname: Whetstone
authors.forename: D M
authors.initials: DM
authors.lastname: Cummings
mesh_terms: D015502:Absorptiometry, Photon; D001741:Black or African American / Q000706:statistics & numerical data*; D000368:Aged; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001851:Bone Diseases, Metabolic / Q000208:ethnology / Q000209:etiology; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D006297:Health Services Accessibility / Q000706:statistics & numerical data; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000208:ethnology* / Q000209:etiology; D012307:Risk Factors; D044465:White People / Q000706:statistics & numerical data*
chemical_list: D050071:Bone Density Conservation Agents